Sangamo Therapeutics
SGMO
#10512
Rank
C$29.38 M
Marketcap
C$0.07093
Share price
0.00%
Change (1 day)
-90.40%
Change (1 year)

Sangamo Therapeutics (SGMO) - Cash on Hand

Cash on Hand as of September 2025 : C$42.01 Million

According to Sangamo Therapeutics 's latest financial reports the company has C$42.01 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Sangamo Therapeutics - Cash on Hand chart (from 2000 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31C$60.15 M-44.01%
2023-12-31C$0.10 B-71.48%
2022-12-31C$0.37 B-21.5%
2021-12-31C$0.47 B-41.32%
2020-12-31C$0.81 B72.76%
2019-12-31C$0.47 B-13.15%
2018-12-31C$0.54 B78.18%
2017-12-31C$0.30 B59.7%
2016-12-31C$0.19 B-33.93%
2015-12-31C$0.28 B39.6%
2014-12-31C$0.20 B110.21%
2013-12-31C$98.79 M56.35%
2012-12-31C$63.19 M-26.16%
2011-12-31C$85.57 M42.01%
2010-12-31C$60.26 M-32.57%
2009-12-31C$89.37 M13.38%
2008-12-31C$78.82 M-2.55%
2007-12-31C$80.89 M28.85%
2006-12-31C$62.77 M14.84%
2005-12-31C$54.66 M36.85%
2004-12-31C$39.94 M-29.78%
2003-12-31C$56.88 M-30.92%
2002-12-31C$82.35 M-16.07%
2001-12-31C$98.12 M3.12%
2000-12-31C$95.15 M768.05%
1999-12-31C$10.96 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
C$31.28 B 74,356.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$17.07 B 40,546.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$6.07 B 14,360.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
C$5.46 B 12,903.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$10.84 B 25,707.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$8.08 B 19,153.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$4.26 B 10,060.79%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$3.15 B 7,404.19%๐Ÿ‡บ๐Ÿ‡ธ USA